Unlearn.AI Company
Unlearn.AI provides a platform that accelerates drug development by pioneering computational clinical trials.
Investors
(Reupload).png)
(Reupload).png)
Technology:
Artificial Intelligence, Bioinformatics, Biopharma, Clinical Trials, Life Science, Machine Learning, Software
Industry:
AI, Clinical Development, United States
Headquarters:
San Francisco, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
69850000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-19
Last Funding Type:
Series B
Register and Claim Ownership